Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Viagra may be useful against Alzheimer's dementia

Viagra may be useful against Alzheimer's dementia

The impotence pill Viagra may be a useful treatment against Alzheimer's disease, say US researchers who have been studying its effects in the brain.

Tests in cells suggest the drug targets some of the proteins that accumulate in this type of dementia.

The Cleveland team also analysed a database of 7m patients and found men who were on the drug had a lower risk of Alzheimer's.

More studies on it are worthwhile, they say in the journal Nature Aging.

Work like this is exciting, say experts, because repurposing an existing drug could be quicker, simpler and cheaper than finding and developing a brand new treatment.

The blue pill


Viagra, also known as sildenafil, was originally designed as a heart drug because of its main action - improving blood flow by relaxing or widening blood vessels.

Doctors then discovered it was having a similar effect elsewhere in the body, including the arteries of the penis, and it was developed into a successful treatment for erectile dysfunction.

But experts think it could have other uses too. Sildenafil is already used in men and women for a lung condition called pulmonary hypertension.

And scientists have recently been exploring whether it might help people at risk of vascular dementia - the second most common form of dementia after Alzheimer's - which occurs when reduced blood flow damages the brain.

Now researchers believe it may help Alzheimer's as well.

The exact cause of this type of dementia is not fully understood, but doctors do know that abnormal protein deposits collect in the brains of people who have it.

The Cleveland team found:

*  High doses of the drug (larger than a person would normally take) increased brain cell growth and reduced protein accumulation in lab studies of human tissue

*  People on sildenafil were less likely to develop Alzheimer's than those not taking this medication, based on personal medical data spanning six years and involving more than 7.23m individuals

Lead investigator Dr Feixiong Cheng said the findings were encouraging, but needed more exploring: "Because our findings only establish an association between sildenafil use and reduced incidence of Alzheimer's disease, we are now planning a mechanistic trial and a phase II randomized clinical trial to test causality and confirm sildenafil's clinical benefits for Alzheimer's patients."

UK brain research expert Prof Tara Spires-Jones, from the University of Edinburgh, said: "More work will be needed to know whether this drug can indeed lower risk for Alzheimer's disease.

"While these data are interesting scientifically, based on this study, I would not rush out to start taking sildenafil as a prevention for Alzheimer's disease."

Dr Jack Auty, lecturer in the Medical Sciences at the University of Tasmania, said: "In the field of Alzheimer's disease research, we have been excited by many drugs over the years, only to have our hopes dashed in clinical trials. I will be following this research group and the research around sildenafil closely."

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

Trump Administration Issues New Travel Ban Targeting 12 Countries
0:00
0:00
Open
Trump Administration Issues New Travel Ban Targeting 12 Countries
0:00
0:00
Close
Trump Administration Issues New Travel Ban Targeting 12 Countries
Man Group Mandates Full-Time Office Return for Quantitative Analysts
JPMorgan Warns Analysts Against Accepting Future-Dated Job Offers
Builder.ai Faces Legal Scrutiny Amid Financial Misreporting Allegations
Japan Grapples with Rice Shortage Amid Soaring Prices
Goldman Sachs Reduces Risk Exposure Amid Market Volatility
HSBC Chairman Mark Tucker to Return to AIA as Non-Executive Chair
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Judge Blocks Trump's Ban on International Students at Harvard
Trump Proposes Travel Ban on 'Uncontrolled' Countries
Global News Roundup: From Ukraine's strategic military strikes and Russia's demands and Tensions Escalate in Ukraine, to serious legal issues faced by Britons in Bali and Trump's media criticism, the latest developments highlight a turbulent landscape
Majority of French Voters View Macron's Presidency as a Failure
Hungary Partners with China to Boost Electric Vehicle Production
‘Vibe Coding’ Emerges as the New DIY Trend
AI Pioneer Yoshua Bengio Warns Models Can Deceive Users
Big Four Firms Rush to Create AI Auditing Systems
Musk’s xAI Pursues $113 Billion Valuation in New Share Sale
Walmart Increases Revenue Despite Shrinking Workforce
Hims & Hers Plans UK and EU Launch of Replica Obesity Drugs
Toyota to Acquire Supplier in $33 Billion Buyout
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
BlackRock-Backed Fintech Aims to Become Europe’s Charles Schwab
China Accuses US of Violating Trade Truce
Europe's Strategic Push to Challenge Dollar Dominance
Iran Warns Europe Against Politicizing UN Nuclear Report
France Implements Nationwide Outdoor Smoking Ban to Protect Children
Macron Lightheartedly Addresses Viral 'Shove' Incident in Indonesia
German Chancellor Merz Keeps Putin Guessing on Missile Strategy
Mandelson Criticizes UK's 'Fetish' for Abandoning EU Regulations
Dutch government falls as far-right leader Wilders quits coalition
Macron and Meloni Seek Unity Despite Tensions
Newark Mayor Sues Over Arrest at Immigration Facility
Center-Left Candidate Projected to Win South Korean Presidency
Trump’s Tariffs Predicted to Stall Global Economic Growth
South Korea’s President-Elect Expected to Take Softer Line on Trump and North Korea
Trump’s China Strategy Remains a Geopolitical Puzzle
Eurozone Inflation Falls Below ECB Target to 1.9%
Blackstone and Rivals Diverge on Private Equity Strategy
Call for a New Chapter in Globalisation Emerges
Ukraine Executes Long-Range Drone Strikes on Russian Airbases
Conservative Karol Nawrocki wins Poland’s presidential election
Study Identifies Potential Radicalization Risk Among Over One Million Muslims in Germany
Good news: Annalena Baerbock Elected President of the UN General Assembly
Apple Appeals EU Law Over User Data Sharing Requirements
South Africa: "First Black Bank" Collapses after Being Looted by Owners
Poland will now withdraw from the EU migration pact after pro-Trump nationalist wins Election
"That's Disgusting, Don’t Say It Again": The Trump Joke That Made the President Boil
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OnlyFans for Sale: From Lockdown Lifeline to Eight-Billion-Dollar Empire
×